Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
JPMorgan Chase delivered its Q3 results on October 13 and the immediate reaction was muted, with the stock slipping 0.9% on the day to $331.43, leaving it essentially flat on the week and still 7% below its August peak.
The options market has returned to neutral ground after the pre-earnings call skew. The put/call ratio closed at 0.9982 on earnings day, back near its 52-week low of 0.963 and nearly one standard deviation below the 20-day mean of 1.06. That is a notable reversal from the heavily defensive positioning that dominated September, when the PCR persistently traded above 1.10. Traders who loaded up on put protection into the summer highs have spent the past month letting it expire rather than rolling it. With the print now out, the positioning story has lost most of its tension. The borrow market remains frictionless: availability is at its absolute ceiling, cost to borrow ticked up to 0.37% from 0.25% last week but is still negligible in absolute terms, and short interest at 0.89% of free float is not a directional signal worth dwelling on.
The more consequential development is what analysts did immediately after the print. Five firms updated their views on October 14, and the direction was broadly constructive. Barclays raised its target to $425, keeping an Overweight rating. Morgan Stanley lifted to $377 with an Equal-Weight. RBC Capital reiterated Outperform at $370. Truist raised to $361 but held at Hold. Baird raised to $312, also at Neutral. The consensus mean target now stands at $372.50. At $331.43, the stock is trading at a 12.4% discount to that average, wider than the 10.6% gap flagged in the pre-earnings note. Bulls point to JPMorgan's fortress balance sheet, a 14.1% CET1 ratio, markets revenue of $12.1 billion, and ROE of 34% in the consumer bank. Bears argue that a large portion of the $21.2 billion Q3 net income included one-time items, expense guidance was raised to roughly $107.5 billion for the full year, and fee-heavy businesses remain exposed if capital markets activity slows. The PE multiple is 13.4 times, down about 0.8 points over the past month, and price-to-book has eased to 2.26, each reflecting the stock's retreat from its summer highs.
The FDIC call report data, published quarterly by the Federal Deposit Insurance Corporation, provides some factual colour on the bank's own balance sheet trajectory. Net loans and leases have risen for nine consecutive quarters, with the latest reading at $1.54 trillion. Total deposits have grown for three consecutive quarters, reaching $2.82 trillion. Neither dataset has enough history yet for ORTEX to measure whether it leads the company's reported figures, so these are descriptive rather than predictive, but the streak itself is a concrete data point that aligns with management's own commentary on loan and deposit growth.
Among peers, the picture on earnings day was broadly weak. WFC fell 3.1% and is down 0.9% on the week. C dropped 5.6% on the day and 3.1% on the week. BAC lost 1.1%. JPMorgan's relative stability after its own print is notable in that context: it fell less than Citigroup did despite both reporting on the same morning.
The next scheduled earnings event is January 14, 2027, giving the Street 92 days to determine whether the post-results analyst target lifts translate into price recovery or simply reflect a consensus that already sits well above where buyers are willing to act.
See the live data behind this article on ORTEX.
Open JPM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
